GlaxoSmithKline Pharmaceuticals Limited
GLAXO
Rankning i aktier
#3776
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Aktiekurs
$25.73
Marknadsvärde
$4.36B
Förändring (1 dag)
-5.33%
Förändring (1 år)
-17.92%
Land
IN
Handel GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Kategori
Healthcare
Aktiekurshistorik för GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Högsta slutkurs: $28.33 den 2026-10-01
Lägsta slutkurs: $7.46 den 1999-01-01
Lägsta slutkurs: $7.46 den 1999-01-01
Aktiekurshistorik för GlaxoSmithKline Pharmaceuticals Limited från 1999 till 2026
Årlig aktiekursutveckling
| År | Prestanda |
|---|---|
| 2026 (TTM) | -0.80% |
| 2025 | 3.53% |
| 2024 | 30.13% |
| 2023 | 28.84% |
| 2022 | -31.26% |
| 2021 | 11.05% |
| 2020 | -8.11% |
| 2019 | 15.01% |
| 2018 | 5.68% |
| 2017 | -5.61% |
| 2016 | -18.58% |
| 2015 | 0.11% |
| 2014 | 11.37% |
| 2013 | 16.93% |
| 2012 | 5.11% |
| 2011 | -25.99% |
| 2010 | 39.42% |
| 2009 | 47.96% |
| 2008 | -8.92% |
| 2007 | -0.02% |
| 2006 | 7.37% |
| 2005 | 41.03% |
| 2004 | 38.71% |
| 2003 | 85.99% |
| 2002 | 3.08% |
| 2001 | -33.62% |
| 2000 | -42.61% |
| 1999 | 0.00% |
Aktiekurs för liknande företag eller konkurrenter
| Företag | Aktiekurs | Förändring 1år% | Land |
|---|---|---|---|
| $1.31K | 61.21% |
US
|
|
| $268.35 | 39.08% |
US
|
|
| $284.58 | 24.44% |
US
|
|
| $147.45 | 68.30% |
US
|
|
| $482.01 | 30.76% |
CH
|
